Sentinel-lymph-node-biopsy in the therapy of breast cancer: Historic overview and recent recommendations;Sentinel-lymphknoten-biopsie in der therapie des mammakarzinoms: Historischer überblick und aktueller stand

Gynakologe

Volumn 37, Issue 8, 2004, Pages 654-661

  Kolberg, H C ^a   Friedrich, M ^a   Diedrich, K ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Axillary dissection; Breast cancer; Nodal status; Prognostic factor; Sentinel lymph node biopsy

Indexed keywords

TECHNETIUM 99M;

AXILLARY LYMPH NODE; BREAST CANCER; HEALTH CARE QUALITY; HISTORY OF MEDICINE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 4544328091     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-004-1560-5     Document Type: Review

References (29)

1. Cabanas R (1977) An approach for the treatment of penile carcinoma. Cancer 39: 456-466
2. Morton DL, Wen DR, Wong JH (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127: 392-399
3. Krag DN, Weaver DL, Alex JC (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335-340
4. Giuliano AE, Kirgan DM, Guenther JM (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-401
5. Albertini JJ, Lyman GH, Cox C (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276: 1818-1822
6. Cody HS, Borgen PI (1999) State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique and quality control at Memorial Sloan Kettering Cancer Center. Surg Oncol 8: 85-91
7. Turner RR, Ollila DW, Krasne DL, Giuliano AE (1997) Histologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226: 271-278
8. Blanchard DK, Donohue JH, Reynolds C, Grant CS (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138: 482-487
9. Roumen RM, Kuijt GP, Liem IH, van Beek MW (2001) Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88: 1639-1643
10. Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L (2003) Sentinel lymph node biopsy alone without axillary lymph node dissection - follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29: 221-223
11. Kühn T, Santjohanser C, Koretz K, Bohm W, Kreienberg R (2000) Axilloscopy and endoscopic sentinel node detection in breast cancer patients. Surg Endosc 14: 573-577
12. Fisher B, Bauer M, Wickerham L, Redmond CK, Fisher ER (1983) Relation of number of positive nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557
13. Bonadonna G, Valagussa P, Moliterni A (1995) Adjuvant cyclophosphamide, methotrexate and flourouracil in node-positive breast cancer: the results of 20 years follow-up. N Engl J Med 332: 901-906
14. Fisher ER, Anderson S, Redmond C, Fisher B (1993) Pathologic findings from the National Surgical Adjuvant Breast Project Protocol B-06: 10 year pathological and clinical prognostic discrimininants. Cancer 71: 2507-2514
15. Carter CL, Allen C, Henderson DE (1989) Relation of tumour size, lymph node status and survival in 24.740 breast cancer cases. Cancer 73: 505-508
16. Fisher B, Slack NH, Ausman RK, Brass IDJ (1969) Location of breast carcinoma and prognosis. Surg Gynec Obstet 129: 7057-7061
17. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal staging in carcinoma of the breast. Surg Gynec Obstet 152: 765-772
18. De Boer R, Hillen HFP, Roumen RMH, Rutten HJT, van der Sangen MJC, Voogd AC (2001) Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg 88: 118-122
19. Recht A, Pierce SM, Abner A (1991) Regional node failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9: 988-996
20. Levine MN, Bramwell VH, Pritchard KI et al. (1998) Randomized trial of intensive cyclophosphamide, epirubicin and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trialists Group. J Clin Oncol 16: 2651-2658
21. Steel RJC, Forrest APM, Gibson T (1985) The efficiacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomised trial. Br J Surg 72: 368-369
22. Kissin MW, Thompson PH, Price AB (1982) The inadequacy of axillary sampling in breast cancer. Lancet 1: 1210-1212
23. Petrek JA, Pressman PI, Smith RA (2000) Lympedema: current issues. Cancer J Clin 50: 292-307
24. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183: 23-27
25. Sener SF, Winchester DJ, Martz CH et al. (2001) Lympedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92: 748-752
26. Carpenter R (2001) Sentinel node biopsy should be introduced into routine practice before results of randomized trials are available. Breast 10: 281-284
27. Orr RK, Hoen JL, Nananda F (1997) The learning curve for sentinel node biopsy in breast cancer. Practical consideration. Arch Surg 134: 764-767
28. Kühn T, Bembenek A, Büchels H et al. (2003) Sentinel-Node-Biopsie beim Mammakarzinom. Interdisziplinär abgestimmter Konsensus der Deutschen Gesellschaft für Senologie für eine qualitätsgesicherte Anwendung in der klinischen Routine. Geburtsh Frauenheilk 63: 835-840
29. Ostertag H, Eidtmann H Jonat W (2000) New procedures in the axilla in patients with breast cancer. Gynäkologe 33: 246-254